The Kingdom of Saudi Arabia, represented by the Saudi Food and Drug Authority (SFDA), will host the 26th Annual Meeting of the Global Harmonization Working Party (GHWP) for Medical Devices, and the scientific and technical working groups' meetings, between February 13 and 16 2023.

Saudi Food and Drug Authority (SFDA) detected a warehouse in Dammam that stored medical supplies without obtaining a license, in addition to not complying with storage requirements.

SFDA also monitored 21,362 medical supplies stored in inappropriate conditions in the violating warehouse, closed it precautionary, and summoned those in charge of it to complete the legal procedures against them, and implement the regulations for medical devices and supplies.

The Saudi Food and Drug Authority (SFDA) organized a scientific program in the field of procedures for regulating medical devices and supplies for the delegation of the National Council for Drugs and Toxins in the Republic of Sudan.

The Saudi Food and Drug Authority (SFDA), in cooperation with the Saudi Basic Industries Corporation (SABIC), organized a workshop to discuss the strategy to support innovators in the field of medical devices and supplies 2023 in Riyadh, as part of the SABIC's "Nusaned" initiative.

Saudi Food and Drug Authority (SFDA) invites interested people in medical devices , manufacturers , and regulatory authorities to register for the 26th annual meeting of the Global Harmonization Working Party (GHWP), which is organized by the Kingdom of Saudi Arabia represented by SFDA during the period from 13 to 16 February 2023 at Crowne Plaza Hotel in Riyadh.

His Excellency the CEO of the Saudi Food and Drug Authority (SFDA), Dr. Hisham bin Saad Aljadhey, met today at the authority’s headquarters in Riyadh, His Excellency the Minister of Health of the Islamic Republic of Mauritania, Moktar Ould Dahi and his accompanying delegation, in the presence of the Ambassador of the Republic of Mauritania to the Kingdom Sidi Ali.

His Excellency the CEO of the Saudi Food and Drug Authority (SFDA), Dr. Hisham bin Saad Aljadhey, met at the authority's headquarters with a number of CEOs of medical devices companies, as part of the program of periodic meetings with the private sector aimed at enhancing communication transparency, partnership and supporting investment.